HYPR
$1.24+0.03 (+2.48%)
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products.
Recent News
Hyperfine (HYPR) Q4 2025 Earnings Call Transcript
Earlier today, Hyperfine Inc. released financial results for the quarter ending December 31, 2025. Before we begin, I'd like to remind that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements.
Hyperfine, Inc. Q4 2025 Earnings Call Summary
Moby summary of Hyperfine, Inc.'s Q4 2025 earnings call
Hyperfine Inc (HYPR) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advances
Hyperfine Inc (HYPR) reports a 128% increase in quarterly revenue and significant gross margin expansion, while navigating challenges in international markets and service revenue.
Hyperfine Q4 Earnings Call Highlights
Hyperfine (NASDAQ:HYPR) reported fourth-quarter results that management said reflected accelerating adoption of its next-generation Swoop portable brain MRI system, driven by improved image quality from its Optive AI software and expanding demand across hospitals, neurology offices, and internationa
Hyperfine Inc (HYPR) Q4 2025: Everything You Need To Know Ahead Of Earnings
This article first appeared on GuruFocus. Hyperfine Inc (NASDAQ:HYPR) is set to release its Q4 2025 earnings on March 18, 2026. The consensus estimate for Q4 2025 revenue is $5.16 million, and the earnings are expected to come in at -$0.08 per share.